ResearcherUniversität UlmActive in the last 2 years
Anton Lahusen
Matched on ORCID iD 0009-0008-8890-2733; OpenAlex author ID A5059915446. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 29
2024: 1 paper · 2025: 2 papers · 2026: 2 papers
Papers 5
- A CXCR4 targeting peptide delivered by silica nanoparticles eliminates migrating cancer stem cells in pancreatic ductal adenocarcinoma. First author DOI 10.1038/s41598-026-48584-2↗
- An oncogenic KRAS-driven secretome involving TNFα promotes niche preparation prior to pancreatic cancer onset. Co-author DOI 10.1186/s12943-025-02541-1↗
- Pancreatic cancer cell-intrinsic transglutaminase-2 promotes T cell suppression through microtubule-dependent secretion of immunosuppressive cytokines. Co-author DOI 10.1136/jitc-2024-010579↗
- An immune responsive tumor microenvironment imprints into PBMCs and predicts outcome in advanced pancreatic cancer: lessons from the PREDICT trial. Co-author DOI 10.1186/s12943-025-02406-7↗
- A pancreatic cancer organoid-in-matrix platform shows distinct sensitivities to T cell killing. Co-author DOI 10.1038/s41598-024-60107-5↗
Closest collaborators
The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Alexander Kleger · 5 shared papers, 2024–2026 · strength 1.08
- Paper Pancreatic cancer cell-intrinsic transglutaminase-2 promotes T cell suppression through microtubule-dependent secretion… DOI 10.1136/jitc-2024-010579↗
- Paper A CXCR4 targeting peptide delivered by silica nanoparticles eliminates migrating cancer stem cells in pancreatic ductal… DOI 10.1038/s41598-026-48584-2↗
- Paper A pancreatic cancer organoid-in-matrix platform shows distinct sensitivities to T cell killing. DOI 10.1038/s41598-024-60107-5↗
- Thomas Theodor Werner Seufferlein · 5 shared papers, 2024–2026 · strength 1.08
- Paper Pancreatic cancer cell-intrinsic transglutaminase-2 promotes T cell suppression through microtubule-dependent secretion… DOI 10.1136/jitc-2024-010579↗
- Paper A CXCR4 targeting peptide delivered by silica nanoparticles eliminates migrating cancer stem cells in pancreatic ductal… DOI 10.1038/s41598-026-48584-2↗
- Paper A pancreatic cancer organoid-in-matrix platform shows distinct sensitivities to T cell killing. DOI 10.1038/s41598-024-60107-5↗
- Tim Eiseler · 3 shared papers, 2024–2025 · strength 0.66
- Paper Pancreatic cancer cell-intrinsic transglutaminase-2 promotes T cell suppression through microtubule-dependent secretion… DOI 10.1136/jitc-2024-010579↗
- Paper A pancreatic cancer organoid-in-matrix platform shows distinct sensitivities to T cell killing. DOI 10.1038/s41598-024-60107-5↗
- Paper An immune responsive tumor microenvironment imprints into PBMCs and predicts outcome in advanced pancreatic cancer: les… DOI 10.1186/s12943-025-02406-7↗
- Yuan‐Na Lin · 2 shared papers, 2024–2025 · strength 0.47
- Anton Wellstein · 2 shared papers, 2024–2025 · strength 0.47
- Kanishka Tiwary · 1 shared paper, 2026 · strength 0.23
- Karolin Walter · 1 shared paper, 2026 · strength 0.23
- Sonia Alcalá · 1 shared paper, 2026 · strength 0.23
- Frank Arnold · 1 shared paper, 2026 · strength 0.23
- Patrick Christian Hermann · 1 shared paper, 2026 · strength 0.23
- Elisabeth Heßmann · 1 shared paper, 2026 · strength 0.23
- Bruno Sáinz · 1 shared paper, 2026 · strength 0.23
- Rui Fang · 1 shared paper, 2025 · strength 0.19
- Phyllis F. Cheung · 1 shared paper, 2025 · strength 0.19
- Andrea Tannapfel · 1 shared paper, 2025 · strength 0.19
- Thomas Jens Ettrich · 1 shared paper, 2025 · strength 0.19
- Meinolf Karthaus · 1 shared paper, 2025 · strength 0.19
- Manfred Paul Lutz · 1 shared paper, 2025 · strength 0.19
- Jens Thomas Siveke · 1 shared paper, 2025 · strength 0.19
- Albrecht Stenzinger · 1 shared paper, 2025 · strength 0.19
- Chantal Allgöwer · 1 shared paper, 2026 · strength 0.19
- Paolo Riccardo Camisa · 1 shared paper, 2026 · strength 0.19
- Benedetta Ferrara · 1 shared paper, 2026 · strength 0.19
- Élodie Roger · 1 shared paper, 2026 · strength 0.19
- Claus Jørgensen · 1 shared paper, 2026 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.